首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Automated perimetry in patients with choroidal metastases.
【2h】

Automated perimetry in patients with choroidal metastases.

机译:脉络膜转移患者的自动视野检查。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

AIMS/BACKGROUND: Recent work using computerised perimetry has documented predictable visual field defects in patients with choroidal melanoma. Despite the higher frequency of occurrence of choroidal metastases, relatively little is known about their exact effects on visual performance, specifically with respect to visual field. This study is a pilot retrospective analysis of the results of automated perimetry testing in patients with choroidal metastatic disease. METHODS: The Humphrey field analyser was used to perform visual field tests on 15 eyes in 11 patients diagnosed with choroidal metastases. All 11 primary tumours were carcinomas originating in the breast (seven), lung (one), kidney (one), stomach (one), and prostate (one). All patients had either central 30 and/or peripheral 30-60 threshold strategies. RESULTS: Each of the 15 eyes tested had a demonstrable visual field defect. Eight eyes (53%) had absolute scotomas and seven (43%) had relative scotomas; the defects did not consistently correspond in size or location to the tumour as depicted by ophthalmoscopy or ultrasonography. This is in contradistinction to automated perimetry results in patients with choroidal melanoma. Three of the four eyes (75%) which were retested after treatment of the metastases showed improvement of the visual field. Seven of nine eyes (77%) that initially had reduced visual acuity had improvement after treatment. This clinical improvement corresponded well to tumour shrinkage and resolution of subretinal fluid. CONCLUSION: These findings may be useful in the decision to initiate treatment for symptomatic choroidal metastatic disease and in explaining to patients and their referring physicians what improvement could be expected from such treatment. A prospective evaluation of patients with choroidal metastases seems appropriate based on this pilot experience and may elucidate if the differences noted between visual field performance of these patients and those with choroidal melanoma may be useful in some diagnostically difficult cases.
机译:目的/背景:最近使用计算机视野检查的工作已记录了脉络膜黑色素瘤患者可预测的视野缺损。尽管脉络膜转移瘤的发生频率较高,但人们对脉络膜转移瘤对视觉性能的确切影响知之甚少,特别是在视野方面。这项研究是对脉络膜转移性疾病患者自动视野检查测试结果的初步回顾性分析。方法:使用汉弗莱视野分析仪对诊断为脉络膜转移的11例患者的15只眼睛进行视野测试。所有11种原发性肿瘤均为源自乳腺癌(七种),肺癌(一种),肾脏(一种),胃(一种)和前列腺(一种)的癌。所有患者均采用中心30和/或外周30-60阈值策略。结果:测试的15只眼睛中的每只眼睛都有明显的视野缺损。八只眼(53%)有绝对性癫痫,七只眼(43%)具有相对性癫痫。如眼底镜检查或超声检查所见,这些缺陷的大小或位置并不一致。这与脉络膜黑色素瘤患者的自动视野检查结果相反。在治疗转移灶后重新测试的四只眼中的三只(75%)显示视野改善。最初视力下降的九只眼中有七只(77%)在治疗后有所改善。这种临床改善与肿瘤缩小和视网膜下液的消退非常吻合。结论:这些发现可能有助于决定是否开始对症状性脉络膜转移性疾病的治疗,并向患者及其转诊医生解释这种治疗可能带来的改善。根据该试验经验,对脉络膜转移瘤患者进行前瞻性评估似乎是适当的,并且可以阐明这些患者和脉络膜黑色素瘤患者的视野表现之间的差异在某些诊断困难的病例中是否有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号